Evidence map›Paper›PMID 39562043›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2025

Optogenetic Control of Dopamine Receptor 2 Reveals a Novel Aspect of Dopaminergic Neurotransmission in Motor Function.

Hyunbin Kim, Geunhong Park, Hyo Geun Shin, Duwan Kwon, Heejung Kim, In-Yeop Baek, Min-Ho Nam, Il-Joo Cho, Jeongjin Kim, Jihye Seong

Abstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A New Optogenetic Tool to Investigate the Role of Dopamine Signaling in the Basal Ganglia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hyunbin KimBrain Science Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea.
Geunhong ParkBrain Science Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea.
Hyo Geun ShinSchool of Electronic and Electrical Engineering, Kyungpook National University, Daegu 41566, Republic of Korea.
Duwan KwonDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Heejung KimDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
In-Yeop BaekBrain Science Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea.
Min-Ho NamBrain Science Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea.
Il-Joo ChoDepartments of Convergence Medicine, Korea University, Seoul 02841, Republic of Korea.
Jeongjin KimBrain Science Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea jihye.seong@snu.ac.kr jeongjin@kist.re.kr.
Jihye SeongDepartment of Pharmacology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea jihye.seong@snu.ac.kr jeongjin@kist.re.kr.ORCID 0000-0001-8450-3315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dopaminergic neurotransmission plays a crucial role in motor function through the coordination of dopamine receptor (DRD) subtypes, such as DRD1 and DRD2, thus the functional imbalance of these receptors can lead to Parkinson's disease. However, due to the complexity of dopaminergic circuits in the brain, it is limited to investigating the individual functions of each DRD subtype in specific brain regions. Here, we developed a light-responsive chimeric DRD2, OptoDRD2, which can selectively activate DRD2-like signaling pathways with spatiotemporal resolution. OptoDRD2 was designed to include the light-sensitive component of rhodopsin and the intracellular signaling domain of DRD2. Upon illumination with blue light, OptoDRD2 triggered DRD2-like signaling pathways, such as Gαi/o subtype recruitment, a decrease in cAMP levels, and ERK phosphorylation. To explore unknown roles of DRD2 in glutamatergic cell populations of basal ganglia circuitry, OptoDRD2 was genetically expressed in excitatory neurons in lateral globus pallidus (LGP) of the male mouse brain. The optogenetic stimulation of OptoDRD2 in the LGP region affected a wide range of locomotion-related parameters, such as increased frequency of movement and decreased immobility time, resulting in the facilitation of motor function of living male mice. Therefore, our findings indicate a potentially novel role for DRD2 in the excitatory neurons of the LGP region, suggesting that OptoDRD2 can be a valuable tool enabling the investigation of unknown roles of DRD2 at specific cell types or brain regions.

Indexed as

OptogeneticsReceptors, Dopamine D2Synaptic TransmissionAnimalsDopamineGlobus PallidusHumansMaleMiceMice, Inbred C57BLMotor ActivityDopamineDRD2 protein, mouseReceptors, Dopamine D2dopamine receptor 2lateral globus pallidus (LGP)motor functionOptoDRD2optogenetics

Identifiers

PMID39562043
PMCPMC11694400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.